Lakewood-Amedex Biotherapeutics Inc (LABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | 12-2024 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12 | 236 | 0 | 681 | N/A |
| Other current assets | 0 | 0 | 0 | 93 | 2,660 |
| TOTAL | $51 | $305 | $0 | $774 | $2,660 |
| Non-Current Assets | |||||
| PPE Net | 8 | 9 | N/A | 77 | N/A |
| Other Non-Current Assets | 138 | 167 | 0 | 9 | 20,270 |
| TOTAL | $146 | $176 | $N/A | $86 | $20,270 |
| Total Assets | $196 | $482 | $0 | $1,071 | $22,930 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 0 | 0 | 2,730 |
| Accounts payable and accrued liabilities | 548 | 381 | 0 | 167 | 17,110 |
| Accrued Expenses | 595 | 304 | 0 | 222 | 2,460 |
| TOTAL | $3,028 | $2,405 | $0 | $501 | $40,390 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10 | 41 | 0 | 0 | 0 |
| TOTAL | $10 | $41 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,038 | $2,446 | $0 | $661 | $40,390 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 700 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 1 | 0 | 1 | 40 |
| Retained earnings | -54,274 | -53,351 | 0 | -49,503 | N/A |
| Other shareholders' equity | -147 | -147 | 0 | -147 | -30 |
| TOTAL | $-2,842 | $-1,965 | $0 | $410 | $23,840 |
| Total Liabilities And Equity | $196 | $482 | $0 | $1,071 | $64,230 |